According to a nearly finalized draft of the communique, the Group of Seven countries (G7) will provide 1 billion doses of the Covid vaccine over the next year and will collaborate with the private sector, the G20, and other countries to increase the contribution in the months ahead.
“The commitments made since our February 2021 meeting, including here in Carbis Bay, provide for one billion doses over the next year,” according to the communique obtained by Reuters.
“Over the coming months, we will work with the private sector, the G20, and other countries to increase this contribution,” the communique stated.
According to two sources, the draft was largely finalized by diplomats who worked late into Saturday night to agree on the majority of the text, though they cautioned that portions of the draft could change in the coming hours.
There were few disagreements over the communique, which is currently undergoing final revisions, though Japan pressed for a tougher stance against China, a diplomatic source said.
The G7 stated in the draft that vaccine donations were based on exports from domestic production, with at least 700 million doses exported or scheduled for export this year, at least half of which went to non-G7 countries.
The group added that it was “committed to maintaining a significant export presence; and to promoting voluntary licensing and not-for-profit global production, which has accounted for 95 percent of COVAX supply to date,” according to the communique.
The World Health Organization (WHO) and the Global Alliance for Vaccines and Immunization (GAVI) have partnered to establish the COVAX facility, which aims to secure 2 billion vaccine doses for low-income countries by the end of 2021.
“We reaffirm our commitment to all ACT-A pillars, including treatments, testing, strengthening public health systems, and vaccines,” the communique stated.
The partnership between ACT and Accelerator was formed to accelerate the development, production, and distribution of vaccines.
“We support discussions about extending the ACT-A mandate through 2022, taking into account the planned comprehensive review to ensure the program’s effectiveness and accountability.”